Fuji Pharma Co., Ltd. (FUP) Ratios
0 Followers
Fuji Pharma Co., Ltd. Ratios
DE:FUP's free cash flow for Q3 2026 was ¥0.00. For the 2026 fiscal year, DE:FUP's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.55 | 1.19 | 1.31 | 1.45 | 1.73 |
| Quick Ratio | 0.86 | 0.68 | 0.66 | 0.79 | 1.13 |
| Cash Ratio | 0.23 | 0.13 | 0.08 | 0.15 | 0.51 |
| Solvency Ratio | 0.15 | 0.22 | 0.15 | 0.14 | 0.14 |
| Operating Cash Flow Ratio | 0.19 | 0.12 | 0.06 | -0.03 | 0.30 |
| Short-Term Operating Cash Flow Coverage | 0.34 | 0.19 | 0.12 | -0.06 | 0.68 |
| Net Current Asset Value | ¥ 1.20B | ¥ -2.54B | ¥ -5.04B | ¥ -5.01B | ¥ 3.27B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.33 | 0.32 | 0.34 | 0.33 | 0.29 |
| Debt-to-Equity Ratio | 0.66 | 0.64 | 0.70 | 0.69 | 0.57 |
| Debt-to-Capital Ratio | 0.40 | 0.39 | 0.41 | 0.41 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.03 | 0.17 | 0.24 | 0.17 |
| Financial Leverage Ratio | 2.00 | 1.99 | 2.07 | 2.11 | 1.97 |
| Debt Service Coverage Ratio | 0.45 | 0.24 | 0.40 | 0.51 | 0.52 |
| Interest Coverage Ratio | 15.12 | 19.80 | 31.88 | 49.05 | 63.19 |
| Debt to Market Cap | 0.70 | 0.77 | 0.89 | 0.87 | 0.49 |
| Interest Debt Per Share | 1281.28 | 1211.39 | 1196.19 | 1014.52 | 696.59 |
| Net Debt to EBITDA | 2.65 | 3.26 | 3.53 | 3.22 | 1.53 |
| Profitability Margins | |||||
| Gross Profit Margin | 37.33% | 35.79% | 40.39% | 41.10% | 43.40% |
| EBIT Margin | 9.66% | 8.41% | 11.02% | 10.66% | 10.07% |
| EBITDA Margin | 17.33% | 16.39% | 18.45% | 18.41% | 16.27% |
| Operating Profit Margin | 9.66% | 8.41% | 9.44% | 10.66% | 9.85% |
| Pretax Profit Margin | 7.74% | 17.94% | 10.76% | 10.51% | 9.92% |
| Net Profit Margin | 5.81% | 13.32% | 8.40% | 7.61% | 7.16% |
| Continuous Operations Profit Margin | 5.81% | 13.33% | 8.40% | 7.61% | 7.16% |
| Net Income Per EBT | 75.00% | 74.28% | 78.09% | 72.41% | 72.14% |
| EBT Per EBIT | 80.16% | 213.24% | 114.02% | 98.57% | 100.66% |
| Return on Assets (ROA) | 3.20% | 6.79% | 4.03% | 3.57% | 3.79% |
| Return on Equity (ROE) | 6.40% | 13.49% | 8.34% | 7.53% | 7.44% |
| Return on Capital Employed (ROCE) | 7.97% | 7.08% | 6.94% | 7.33% | 7.60% |
| Return on Invested Capital (ROIC) | 4.65% | 3.71% | 4.15% | 4.37% | 4.51% |
| Return on Tangible Assets | 3.76% | 7.87% | 4.59% | 4.14% | 3.93% |
| Earnings Yield | 7.95% | 19.86% | 12.12% | 10.73% | 7.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.83 | 2.44 | 2.48 | 2.80 | 2.84 |
| Payables Turnover | 7.09 | 7.16 | 4.30 | 3.34 | 3.37 |
| Inventory Turnover | 1.53 | 1.65 | 1.26 | 1.32 | 1.60 |
| Fixed Asset Turnover | 2.47 | 2.21 | 1.99 | 1.89 | 2.36 |
| Asset Turnover | 0.55 | 0.51 | 0.48 | 0.47 | 0.53 |
| Working Capital Turnover Ratio | 4.38 | 5.76 | 4.07 | 2.79 | 1.76 |
| Cash Conversion Cycle | 316.73 | 320.18 | 352.61 | 297.91 | 248.08 |
| Days of Sales Outstanding | 129.13 | 149.35 | 147.47 | 130.45 | 128.69 |
| Days of Inventory Outstanding | 239.10 | 221.83 | 290.08 | 276.77 | 227.78 |
| Days of Payables Outstanding | 51.51 | 51.01 | 84.94 | 109.31 | 108.39 |
| Operating Cycle | 368.23 | 371.19 | 437.55 | 407.22 | 356.47 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 237.72 | 170.75 | 78.88 | -27.09 | 223.06 |
| Free Cash Flow Per Share | 156.54 | 56.48 | -81.48 | -538.46 | 78.05 |
| Dividend Paid and CapEx Coverage Ratio | 1.92 | 1.11 | 0.40 | -0.05 | 1.27 |
| Capital Expenditure Coverage Ratio | 2.93 | 1.49 | 0.49 | -0.05 | 1.54 |
| Operating Cash Flow Coverage Ratio | 0.19 | 0.14 | 0.07 | -0.03 | 0.32 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.09 | 0.05 | -0.02 | 0.18 |
| Free Cash Flow Yield | 10.13% | 4.44% | -6.99% | -52.08% | 6.67% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.58 | 5.03 | 8.25 | 9.32 | 12.93 |
| Price-to-Sales (P/S) Ratio | 0.73 | 0.67 | 0.69 | 0.71 | 0.92 |
| Price-to-Book (P/B) Ratio | 0.80 | 0.68 | 0.69 | 0.70 | 0.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 9.88 | 22.54 | -14.31 | -1.92 | 14.99 |
| Price-to-Operating Cash Flow Ratio | 6.50 | 7.46 | 14.78 | -38.17 | 5.25 |
| Price-to-Earnings Growth (PEG) Ratio | -0.24 | 0.06 | 0.30 | 0.41 | 0.37 |
| Enterprise Value Multiple | 6.86 | 7.36 | 7.29 | 7.07 | 7.21 |
| Enterprise Value | 61.42B | 55.62B | 54.96B | 46.14B | 39.90B |
| EV to EBITDA | 6.86 | 7.36 | 7.29 | 7.07 | 7.21 |
| EV to Sales | 1.19 | 1.21 | 1.34 | 1.30 | 1.17 |
| EV to Free Cash Flow | 16.08 | 40.51 | -27.76 | -3.53 | 19.03 |
| EV to Operating Cash Flow | 10.59 | 13.40 | 28.67 | -70.12 | 6.66 |
| Tangible Book Value Per Share | 1351.02 | 1362.39 | 1262.61 | 1045.52 | 1127.16 |
| Shareholders’ Equity Per Share | 1922.10 | 1874.05 | 1694.23 | 1473.71 | 1216.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.26 | 0.22 | 0.28 | 0.28 |
| Revenue Per Share | 2117.65 | 1897.82 | 1682.58 | 1458.27 | 1265.14 |
| Net Income Per Share | 122.94 | 252.85 | 141.35 | 110.98 | 90.52 |
| Tax Burden | 0.75 | 0.74 | 0.78 | 0.72 | 0.72 |
| Interest Burden | 0.80 | 2.13 | 0.98 | 0.99 | 0.98 |
| Research & Development to Revenue | 0.06 | 0.07 | 0.08 | 0.07 | 0.07 |
| SG&A to Revenue | 0.21 | 0.20 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.93 | 0.68 | 0.44 | -0.18 | 1.78 |
Currency in JPY
